Tandem Diabetes Care (TNDM) Stock Price, Quote & News

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 366 6900

Website: www.tandemdiabetes.com

Address:

12400 High Bluff Drive, San Diego, United States

topstockalerts Mar. 19 at 1:39 PM

$TNDM more structured chart here, not a low float lottery. Could attract swing traders if it holds support and builds higher.

0 · Reply

erevnon Mar. 19 at 11:46 AM

Truist Securities upgrades Tandem Diabetes Care $TNDM from Hold to Buy and raises the price target from $27 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

anachartanalyst Mar. 19 at 11:01 AM

$TNDM https://anachart.com/wp-content/uploads/ana_temp/1773918069_soc-img.jpg

0 · Reply

topstockalerts Mar. 17 at 5:17 PM

$TNDM When company updates drop, this one tends to get steady attention. Moves here usually develop with sustained volume rather than spikes.

0 · Reply

Punpire Mar. 17 at 2:34 PM

$TNDM ...

1 · Reply

StockElementCorporation Mar. 17 at 12:59 PM

Premarket movers 📈 Upside: $LIDR +32% — earnings; joins NVIDIA AI safety lab $JVA +25% — earnings $CTRN +18% — earnings $OKLO +5.9% — NRC license granted $TNDM +5.5% — analyst upgrade DAL +5.1% — raises guidance UBER +3.8% — NVIDIA robotaxi rollout AAL +3.7% — sympathy with DAL LYFT +3.5% — AI + autonomous push JHG +3.3% — raised buyout offer MU +2.5% — HBM4 production ramp TH +2.5% — positive commentary Downside: ALDX -68% — FDA rejection

0 · Reply

DonCorleone77 Mar. 17 at 11:07 AM

$TNDM Tandem Diabetes upgraded to Overweight from Neutral at Piper Sandler Piper Sandler analyst Matt O'Brien upgraded Tandem Diabetes to Overweight from Neutral with a price target of $33, up from $21. Piper upgrades the shares following an analysis of Tandem's pharmacy pricing benefit and international direct market opportunities. The firm sees "meaningful upside" to the company's revenue estimates over the next three years. This, coupled with a "modest" valuation, should push Tandem shares higher from current levels, the analyst tells investors in a research note. Piper thinks the company's new tubeless Mobi product should buoy pump shipments and help Tandem get back to taking some share in the market.

0 · Reply

erevnon Mar. 17 at 10:51 AM

Piper Sandler upgrades Tandem Diabetes Care $TNDM from Neutral to Overweight and raises the price target from $21 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

notreload_ai Mar. 17 at 10:29 AM

Piper Sandler upgrades $TNDM to Overweight from Neutral, raises PT to $33 from $21. Mobi pump, pharmacy pricing, and international growth drive revenue upside. https://notreload.xyz/tandem-diabetes-stock-gets-a-boost-analyst-upgrade-signals-upside-potential/

0 · Reply

anachartanalyst Mar. 17 at 10:01 AM

$TNDM https://anachart.com/wp-content/uploads/ana_temp/1773741668_soc-img.jpg

0 · Reply

Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence

Mar 4, 2026, 5:00 PM EST - 17 days ago

Tandem Mobi Now Compatible with Android Smartphones

Feb 26, 2026, 5:08 PM EST - 23 days ago

Tandem Diabetes Care, Inc. (TNDM) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript

Feb 25, 2026, 12:30 AM EST - 24 days ago

Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032

Feb 23, 2026, 4:05 PM EST - 26 days ago

Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes

Feb 23, 2026, 11:58 AM EST - 26 days ago

Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition

Feb 20, 2026, 1:01 PM EST - 4 weeks ago

Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook

Feb 20, 2026, 11:58 AM EST - 4 weeks ago

Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results

Feb 20, 2026, 2:24 AM EST - 4 weeks ago

Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 4:05 PM EST - 4 weeks ago

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance

Feb 12, 2026, 4:05 PM EST - 5 weeks ago

Tandem Diabetes Care Announces Upcoming Conference Presentations

Jan 8, 2026, 4:05 PM EST - 2 months ago

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Dec 18, 2025, 9:00 AM EST - 3 months ago

Tandem t:slim Mobile App Now Available in Canada

Nov 12, 2025, 9:00 AM EST - 4 months ago

Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors

Nov 10, 2025, 8:30 AM EST - 4 months ago

Tandem Mobi Receives FDA Clearance for Use with Android Smartphones

Nov 6, 2025, 9:16 PM EST - 4 months ago

Tandem Diabetes Care, Inc. (TNDM) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 months ago

Tandem Diabetes Care Announces Third Quarter 2025 Financial Results

Nov 4, 2025, 8:30 AM EST - 4 months ago

Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards

Oct 29, 2025, 8:30 AM EDT - 5 months ago

t:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States

Oct 16, 2025, 4:23 AM EDT - 5 months ago

TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm

Oct 2, 2025, 4:05 PM EDT - 6 months ago

Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025

Sep 29, 2025, 8:30 AM EDT - 6 months ago

Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States

Sep 16, 2025, 8:30 AM EDT - 6 months ago

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels

Sep 10, 2025, 11:40 AM EDT - 6 months ago

Tandem Diabetes Care, Inc. (TNDM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 4, 2025, 8:30 AM EDT - 7 months ago

Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones

Aug 11, 2025, 8:01 AM EDT - 7 months ago

Top 3 Health Care Stocks That Are Preparing To Pump This Month

EXAS OM

Aug 10, 2025, 7:30 AM EDT - 7 months ago

Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell

Aug 7, 2025, 9:32 AM EDT - 8 months ago

Tandem Diabetes Care issues voluntary device correction for certain insulin pumps

Aug 7, 2025, 8:30 AM EDT - 8 months ago

Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps

Aug 7, 2025, 8:14 AM EDT - 8 months ago

Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

FTNT SYM

Aug 7, 2025, 2:00 AM EDT - 8 months ago

Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 8 months ago

Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance

Jul 31, 2025, 4:05 PM EDT - 8 months ago

Tandem Diabetes Care Announces Upcoming Conference Participation

Jul 1, 2025, 4:05 PM EDT - 9 months ago

Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025

Jun 20, 2025, 8:30 AM EDT - 9 months ago

Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States

Jun 10, 2025, 8:30 AM EDT - 10 months ago

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor

Apr 30, 2025, 8:11 PM EDT - 11 months ago

Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call Transcript

Apr 30, 2025, 4:05 PM EDT - 11 months ago

Tandem Diabetes Care Announces First Quarter 2025 Financial Results

Apr 3, 2025, 4:05 PM EDT - 1 year ago

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Mar 19, 2025, 10:00 AM EDT - 1 year ago

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

Feb 27, 2025, 12:44 PM EST - 1 year ago

Tandem Diabetes Q4 Earnings Review: I Don't Share The Market's Skepticism

Feb 27, 2025, 1:04 AM EST - 1 year ago

Tandem Diabetes Care, Inc. (TNDM) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 1 year ago

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance

Feb 25, 2025, 8:30 AM EST - 1 year ago

Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Jan 15, 2025, 4:05 PM EST - 1 year ago

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Jan 7, 2025, 9:00 AM EST - 1 year ago

Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems

Dec 10, 2024, 9:00 AM EST - 1 year ago

Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada

Nov 6, 2024, 9:21 PM EST - 1 year ago

Tandem Diabetes Care, Inc. (TNDM) Q3 2024 Earnings Conference Call Transcript

topstockalerts Mar. 19 at 1:39 PM

$TNDM more structured chart here, not a low float lottery. Could attract swing traders if it holds support and builds higher.

0 · Reply

erevnon Mar. 19 at 11:46 AM

Truist Securities upgrades Tandem Diabetes Care $TNDM from Hold to Buy and raises the price target from $27 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

anachartanalyst Mar. 19 at 11:01 AM

$TNDM https://anachart.com/wp-content/uploads/ana_temp/1773918069_soc-img.jpg

0 · Reply

topstockalerts Mar. 17 at 5:17 PM

$TNDM When company updates drop, this one tends to get steady attention. Moves here usually develop with sustained volume rather than spikes.

0 · Reply

Punpire Mar. 17 at 2:34 PM

$TNDM ...

1 · Reply

StockElementCorporation Mar. 17 at 12:59 PM

0 · Reply

DonCorleone77 Mar. 17 at 11:07 AM

0 · Reply

erevnon Mar. 17 at 10:51 AM

Piper Sandler upgrades Tandem Diabetes Care $TNDM from Neutral to Overweight and raises the price target from $21 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

notreload_ai Mar. 17 at 10:29 AM

0 · Reply

anachartanalyst Mar. 17 at 10:01 AM

$TNDM https://anachart.com/wp-content/uploads/ana_temp/1773741668_soc-img.jpg

0 · Reply

theflynews Mar. 17 at 8:44 AM

Tandem Diabetes just upgraded at Piper Sandler, here's why - $TNDM - https://thefly.com/TNDM

0 · Reply

StockConsultant Mar. 16 at 1:11 PM

$TNDM Tandem Diabetes Care stock with local support and resistance areas at 18.62, 21.26, 22.8 and 26.23, from https://stockconsultant.com/?TNDM

0 · Reply

OfficialStocktwitsUser Mar. 13 at 7:55 PM

$TNDM RSI: 18.71, MACD: 0.1259 Vol: 2.89, MA20: 22.78, MA50: 21.43 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Punpire Mar. 9 at 7:35 PM

$TNDM This stock is schizophrenic

1 · Reply

TraderRapp Mar. 6 at 10:40 PM

$TNDM didn’t think it would try to fill the gap to $18-20, but you see why I see.

1 · Reply

xslim12 Mar. 6 at 3:32 PM

$TNDM POS tandem - gave up so much of those post earnings gains

0 · Reply

Alderson95 Mar. 6 at 5:12 AM

$ABT $DXCM $PODD $SENS $TNDM

0 · Reply

JInvestTrade Mar. 6 at 4:24 AM

$SENS $DXCM $ABT $TNDM $PODD https://www.linkedin.com/posts/senseonics-incorporated-gets-fda-investigational-share-7434771429893746688-59if?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_campaign=copy_link

0 · Reply

surrealskillerr Mar. 6 at 2:38 AM

$TNDM $DXCM what do people think about MiniMed IPO (spinoff from Medtronic) ? MiniMed is a very good pump, it was the best before Tandem came on market. CGM is good but a bit behind Dexcom.

1 · Reply

SuperGreenToday Mar. 4 at 3:39 PM

$TNDM Share Price: $24.00 Contract Selected: Aug 21, 2026 $25 Calls Buy Zone: $2.72 – $3.36 Target Zone: $4.73 – $5.78 Potential Upside: 64% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

stockpicker63 Feb. 28 at 9:53 AM

Results this week can once again be called outstanding. Our system is fully up to date. Best trades this week: $IBRX +17.8%, $TNDM +14%, $KEYS +10%, $JAZZ +9%, $SGHC +8.5%. We are now fully on the sidelines, waiting to see what next week brings. Check out all trades on the website.

0 · Reply

IN0V8 Feb. 25 at 7:11 PM

$TNDM 2/24 BofA Global Research raises PO to $35 from $30

0 · Reply

Market Cap	1.63B
Revenue (ttm)	1.01B
Net Income (ttm)	-204.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-20.17%
Debt to Equity Ratio	0.00

Volume	2,424,000
Avg Vol	2,097,390
Day's Range	N/A - N/A
Shares Out	68.33M
Stochastic %K	88%
Beta	1.63
Analysts	Sell
Price Target	$29.57